Biotheryx, Inc., a biopharmaceutical company focused on the discovery and development of first-in-class protein degraders for cancer and inflammatory diseases, today announced that the first patient ...
Peet opened up about her breast cancer diagnosis in an essay published by 'The New Yorker' ...
The Quezon City government has partnered with SM Malls to launch a mass breast milk donation drive aimed at boosting the city ...
New York has been missing one of its most consequential institutions of contemporary art for two years now, ever since the ...
Greenwich LifeSciences has added City of Hope to its Phase III FLAMINGO-01 clinical trial, which is investigating the ...
Novartis has committed up to $3 billion—two-thirds of that upfront—toward acquiring Pikavation Therapeutics, a subsidiary of Synnovation Therapeutics that specializes in developing PI3Kα inhibitor ...
She describes that assignment as formative, and it helps explain why she now speaks about insurance through the lens of ...
In a 2017 report, the EPA said it could be safe to eat one fish a week from the Hudson in "55 years or more." That's in 2072 ...
Nearly 30 years after South Africa’s Constitution promised dignity and equality for all, too many women continue to live in ...
In his first interview with KARE 11 since ending his re-election campaign, Gov. Walz talked about the decision, his handing ...
Innovation and Globalization Propel Fosun Pharma's High-Quality Growth SHANGHAI, March 24, 2026 /PRNewswire/ -- On 24 March, 2026, Fosun Pharma ("the company", stock ...
"Putting on grips and chalking up for the first time [in years] brought tears to my eyes," Angela Fuller tells PEOPLE. "I ...